Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Satwik Rajaram

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Medrxiv : the Preprint Server for Health Sciences|December 3, 2025
Radiologic, Pathologic, and Deep Learning Predictors of Response to Immune Checkpoint Blockade in Renal Cell Carcinoma Patients Undergoing Post-Treatment NephrectomyPayal Kapur, Alana Christie, Vipul Jarmale, et al.
Biorxiv : the Preprint Server for Biology|July 3, 2026
A Visually Interpretable Histopathology-Based Immune Model Predicts T-effector Biology and Response to Immune checkpoint inhibition in Clear Cell Renal Cell Carcinoma Clinical Trial and Contemporary Real-World DatasetsAveri Perny, Vipul Jarmale, Jay Jasti, et al.
Biorxiv : the Preprint Server for Biology|December 18, 2025
Resolving phenotyping discordance with SPACEMAP, an integrated machine learning frameworkBassel Dawod, Arely Perez Rodriguez, Sebastian Diegeler, et al.
Cancer Research|April 6, 2017
Combination Therapy Targeting BCL6 and Phospho-STAT3 Defeats Intratumor Heterogeneity in a Subset of Non-Small Cell Lung CancersDhruba Deb, Satwik Rajaram, Jill E Larsen, et al.
Nature Methods|September 5, 2017
Sampling strategies to capture single-cell heterogeneitySatwik Rajaram, Louise E Heinrich, John D Gordan, et al.
Arxiv|June 10, 2024
Histopathology Based AI Model Predicts Anti-Angiogenic Therapy Response in Renal Cancer Clinical TrialJay Jasti, Hua Zhong, Vandana Panwar, et al.
Nature Communications|March 18, 2025
Histopathology based AI model predicts anti-angiogenic therapy response in renal cancer clinical trialJay Jasti, Hua Zhong, Vandana Panwar, et al.
Journal of Neuropathology and Experimental Neurology|October 8, 2019
Distinct Expression Patterns of Carbonic Anhydrase IX in Clear Cell, Microcystic, and Angiomatous MeningiomasRati Chkheidze, Patrick J Cimino, Kimmo J Hatanpaa, et al.
Nature Communications|February 20, 2016
Diverse drug-resistance mechanisms can emerge from drug-tolerant cancer persister cellsMichael Ramirez, Satwik Rajaram, Robert J Steininger, et al.
Biorxiv : the Preprint Server for Biology|December 23, 2024
Caveolin-1 regulates context-dependent signaling and survival in Ewing sarcomaDagan Segal, Xiaoyu Wang, Hanieh Mazloom-Farisbaf, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Medrxiv : the Preprint Server for Health Sciences|December 3, 2025
Radiologic, Pathologic, and Deep Learning Predictors of Response to Immune Checkpoint Blockade in Renal Cell Carcinoma Patients Undergoing Post-Treatment NephrectomyPayal Kapur, Alana Christie, Vipul Jarmale, et al.
Biorxiv : the Preprint Server for Biology|July 3, 2026
A Visually Interpretable Histopathology-Based Immune Model Predicts T-effector Biology and Response to Immune checkpoint inhibition in Clear Cell Renal Cell Carcinoma Clinical Trial and Contemporary Real-World DatasetsAveri Perny, Vipul Jarmale, Jay Jasti, et al.
Biorxiv : the Preprint Server for Biology|December 18, 2025
Resolving phenotyping discordance with SPACEMAP, an integrated machine learning frameworkBassel Dawod, Arely Perez Rodriguez, Sebastian Diegeler, et al.
Cancer Research|April 6, 2017
Combination Therapy Targeting BCL6 and Phospho-STAT3 Defeats Intratumor Heterogeneity in a Subset of Non-Small Cell Lung CancersDhruba Deb, Satwik Rajaram, Jill E Larsen, et al.
Nature Methods|September 5, 2017
Sampling strategies to capture single-cell heterogeneitySatwik Rajaram, Louise E Heinrich, John D Gordan, et al.
Arxiv|June 10, 2024
Histopathology Based AI Model Predicts Anti-Angiogenic Therapy Response in Renal Cancer Clinical TrialJay Jasti, Hua Zhong, Vandana Panwar, et al.
Nature Communications|March 18, 2025
Histopathology based AI model predicts anti-angiogenic therapy response in renal cancer clinical trialJay Jasti, Hua Zhong, Vandana Panwar, et al.
Journal of Neuropathology and Experimental Neurology|October 8, 2019
Distinct Expression Patterns of Carbonic Anhydrase IX in Clear Cell, Microcystic, and Angiomatous MeningiomasRati Chkheidze, Patrick J Cimino, Kimmo J Hatanpaa, et al.
Nature Communications|February 20, 2016
Diverse drug-resistance mechanisms can emerge from drug-tolerant cancer persister cellsMichael Ramirez, Satwik Rajaram, Robert J Steininger, et al.
Biorxiv : the Preprint Server for Biology|December 23, 2024
Caveolin-1 regulates context-dependent signaling and survival in Ewing sarcomaDagan Segal, Xiaoyu Wang, Hanieh Mazloom-Farisbaf, et al.
Pageof 4